Subsequently, elevated miR- 34a suppressesexpression of SIRT1, which then further decreases FXR activity, resulting in a viciousFXR/miR-34a/SIRT1 regulatory loop in metabolic disease states. This evidence concerns the gene NR1H4 and Other metabolic disease.